PL3443071T3 - Nowe gatunki bakterii - Google Patents
Nowe gatunki bakteriiInfo
- Publication number
- PL3443071T3 PL3443071T3 PL17716253T PL17716253T PL3443071T3 PL 3443071 T3 PL3443071 T3 PL 3443071T3 PL 17716253 T PL17716253 T PL 17716253T PL 17716253 T PL17716253 T PL 17716253T PL 3443071 T3 PL3443071 T3 PL 3443071T3
- Authority
- PL
- Poland
- Prior art keywords
- bacterial species
- novel bacterial
- novel
- species
- bacterial
- Prior art date
Links
- 230000001580 bacterial effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16164743 | 2016-04-11 | ||
| EP17716253.4A EP3443071B1 (en) | 2016-04-11 | 2017-04-11 | Novel bacterial species |
| PCT/EP2017/058700 WO2017178496A1 (en) | 2016-04-11 | 2017-04-11 | Novel bacterial species |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3443071T3 true PL3443071T3 (pl) | 2022-03-28 |
Family
ID=55755363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17716253T PL3443071T3 (pl) | 2016-04-11 | 2017-04-11 | Nowe gatunki bakterii |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US11202807B2 (pl) |
| EP (1) | EP3443071B1 (pl) |
| JP (1) | JP7012377B2 (pl) |
| KR (1) | KR20180133443A (pl) |
| CN (1) | CN109415683B (pl) |
| AU (1) | AU2017251253B2 (pl) |
| CA (1) | CA3020454A1 (pl) |
| DK (1) | DK3443071T3 (pl) |
| EA (1) | EA201800564A1 (pl) |
| ES (1) | ES2905784T3 (pl) |
| IL (1) | IL262258B (pl) |
| MX (1) | MX386592B (pl) |
| PL (1) | PL3443071T3 (pl) |
| PT (1) | PT3443071T (pl) |
| WO (1) | WO2017178496A1 (pl) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3423093A4 (en) | 2016-03-04 | 2019-11-13 | The Regents of The University of California | MICROBIAL CONSORTIUM AND USES THEREOF |
| PL3443071T3 (pl) * | 2016-04-11 | 2022-03-28 | Wageningen Universiteit | Nowe gatunki bakterii |
| WO2019194130A1 (ja) * | 2018-04-05 | 2019-10-10 | 丸共バイオフーズ株式会社 | 新規ムチン型糖タンパク質およびその用途 |
| EP3773645A4 (en) | 2018-04-10 | 2021-11-24 | Siolta Therapeutics, Inc. | MICROBIAL CONSORTIA |
| CN110227085A (zh) * | 2019-07-16 | 2019-09-13 | 江苏省中医院 | Akkermansia Muciniphila在制备抗抑郁药物或者保健品中的应用 |
| KR102397916B1 (ko) * | 2019-10-01 | 2022-05-17 | (주)헬스바이옴 | 건강한 임산부 모유 유래 혐기성 인체 균주 및 이를 이용한 대사성 질환의 예방 또는 치료방법 |
| WO2021071864A1 (en) | 2019-10-07 | 2021-04-15 | Siolta Therapeutics, Inc. | Therapeutic pharmaceutical compositions |
| GB201915144D0 (en) * | 2019-10-18 | 2019-12-04 | Multigerm Uk Entpr Ltd | Method of promoting SCFA production by gut microbiota |
| JP2023516525A (ja) * | 2019-12-26 | 2023-04-20 | 広州市基准医療有限公司 | Ｄｎａメチル化バイオマーカーの組み合わせ、検出方法および試薬キット |
| CN111304133B (zh) * | 2020-03-20 | 2023-01-13 | 苏州普瑞森生物科技有限公司 | 一种培养嗜黏蛋白阿克曼氏菌的培养基及其使用方法和应用 |
| AU2021246535A1 (en) * | 2020-04-03 | 2022-10-27 | International N&H Denmark Aps | Composition comprising bacterial strains for improving metabolic health |
| KR102380194B1 (ko) * | 2021-06-11 | 2022-03-29 | 쿼럼바이오 주식회사 | 갈락토오스를 포함하는 장내 미생물 개체군 개선용 조성물 |
| BE1029496B1 (fr) | 2021-08-19 | 2023-01-16 | The Akkermansia Company | Composition comprenant de l'Akkermansia muciniphila pasteurisée pour le traitement ou la prévention des troubles de la contractilité intestinale, en particulier des troubles de l'amplitude de la contractilité duodénale |
| BE1029502B1 (fr) | 2021-08-19 | 2023-01-17 | The Akkermansia Company | Composition comprenant de l'Akkermansia muciniphila pasteurisée pour le traitement ou la prévention de l'anxiété liée au syndrome du côlon irritable |
| KR102643788B1 (ko) * | 2021-12-08 | 2024-03-07 | (주)헬스바이옴 | 아커만시아속 미생물의 고수율 생산용 배지 조성물, 그를 이용한 배양방법 및 동결건조 방법 |
| JPWO2023224117A1 (pl) * | 2022-05-20 | 2023-11-23 | ||
| CN115252651B (zh) * | 2022-06-08 | 2024-06-07 | 广州知易生物科技有限公司 | 嗜粘蛋白阿克曼菌在制备防治高血压的组合物中的应用和含有其的组合物 |
| FR3138770A1 (fr) * | 2022-08-10 | 2024-02-16 | Actina | Ensemble de parties destine a moduler le microbiote intestinale, reduire la prise de poids et le stockage des graisses dans le foie |
| CN117796528B (zh) * | 2023-12-29 | 2024-12-31 | 广西爱生生命科技有限公司 | 广西阿克曼氏菌菌株或其益生菌剂在制备延长寿命、抗衰老、延缓帕金森病的产品中的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101982491B1 (ko) | 2011-08-30 | 2019-05-27 | 아카데미쉬 메디쉬 센트륨 | 인슐린 저항 예방 및/또는 치료 방법 |
| CN104540962B (zh) * | 2012-08-01 | 2017-09-19 | 深圳华大基因研究院 | 糖尿病生物标志物及其应用 |
| WO2014075745A1 (en) | 2012-11-19 | 2014-05-22 | Université Catholique de Louvain | Use of akkermansia for treating metabolic disorders |
| US20140242654A1 (en) | 2013-02-26 | 2014-08-28 | Coskata, Inc. | Butyrate Producing Clostridium species, Clostridium pharus |
| WO2014150094A1 (en) | 2013-03-15 | 2014-09-25 | University Of Florida Research Foundation, Inc. | Butyrogenic bacteria as probiotics to treat clostridium difficile |
| JP6925280B2 (ja) * | 2015-05-06 | 2021-08-25 | ヴァーヘニンゲン ユニバーシテイト | アッカーマンシアの培養方法 |
| BR112018004532B1 (pt) * | 2015-09-10 | 2022-03-15 | Université Catholique de Louvain | Uso de akkermansia pasteurizado para o tratamento de distúrbios metabólicos |
| EP3359171B1 (en) * | 2015-10-05 | 2023-07-05 | Schweizerisches Forschungsinstitut für Hochgebirgsklima und Medizin in Davos | Use of akkermansia muciniphila for treating inflammatory conditions |
| KR20180113535A (ko) * | 2016-02-25 | 2018-10-16 | 카엘루스 파마슈티컬스 비.브이. | 비타민 b12 결핍을 예방 및/또는 치료를 위한 조성물 및 방법 |
| PL3443071T3 (pl) * | 2016-04-11 | 2022-03-28 | Wageningen Universiteit | Nowe gatunki bakterii |
| CN110551658A (zh) * | 2019-09-12 | 2019-12-10 | 君维安(武汉)生命科技有限公司 | 一种嗜黏蛋白阿克曼氏菌的低氧培养方法 |
-
2017
- 2017-04-11 PL PL17716253T patent/PL3443071T3/pl unknown
- 2017-04-11 WO PCT/EP2017/058700 patent/WO2017178496A1/en not_active Ceased
- 2017-04-11 DK DK17716253.4T patent/DK3443071T3/da active
- 2017-04-11 JP JP2019503784A patent/JP7012377B2/ja active Active
- 2017-04-11 PT PT177162534T patent/PT3443071T/pt unknown
- 2017-04-11 ES ES17716253T patent/ES2905784T3/es active Active
- 2017-04-11 CN CN201780031808.8A patent/CN109415683B/zh active Active
- 2017-04-11 EA EA201800564A patent/EA201800564A1/ru unknown
- 2017-04-11 CA CA3020454A patent/CA3020454A1/en active Pending
- 2017-04-11 EP EP17716253.4A patent/EP3443071B1/en active Active
- 2017-04-11 KR KR1020187031725A patent/KR20180133443A/ko not_active Ceased
- 2017-04-11 AU AU2017251253A patent/AU2017251253B2/en active Active
- 2017-04-11 MX MX2018012408A patent/MX386592B/es unknown
- 2017-04-11 US US16/093,041 patent/US11202807B2/en active Active
-
2018
- 2018-10-10 IL IL262258A patent/IL262258B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| MX386592B (es) | 2025-03-19 |
| NZ747179A (en) | 2024-07-05 |
| BR112018070962A2 (pt) | 2019-01-29 |
| IL262258B (en) | 2021-03-25 |
| ES2905784T3 (es) | 2022-04-12 |
| CN109415683B (zh) | 2022-04-15 |
| MX2018012408A (es) | 2019-06-17 |
| US20190183941A1 (en) | 2019-06-20 |
| EA201800564A1 (ru) | 2019-06-28 |
| DK3443071T3 (da) | 2022-01-31 |
| US11202807B2 (en) | 2021-12-21 |
| CA3020454A1 (en) | 2017-10-19 |
| CN109415683A (zh) | 2019-03-01 |
| EP3443071B1 (en) | 2022-01-05 |
| JP2019510520A (ja) | 2019-04-18 |
| WO2017178496A1 (en) | 2017-10-19 |
| EP3443071A1 (en) | 2019-02-20 |
| JP7012377B2 (ja) | 2022-02-14 |
| KR20180133443A (ko) | 2018-12-14 |
| AU2017251253A1 (en) | 2018-11-01 |
| IL262258A (en) | 2018-11-29 |
| AU2017251253B2 (en) | 2023-01-05 |
| PT3443071T (pt) | 2022-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL262258A (en) | A new bacterial species | |
| PL3380108T3 (pl) | Zaprojektowane kompozycje bakteryjne | |
| SG11201705416XA (en) | Bacterial compositions | |
| GB2600653B (en) | Novel methods | |
| EP3504315A4 (en) | BIOREACTOR | |
| DK3532170T3 (da) | Aerosolspray indeholdende levedygtige bakteriearter | |
| EP3260529A4 (en) | Incubator | |
| IL253635A0 (en) | Cyclopropanebenzofuranyl pyridopyrazinedione type compounds | |
| GB201617548D0 (en) | Novel biological factor | |
| GB201612242D0 (en) | Novel kit | |
| GB201603320D0 (en) | Enhancing photosynthesis | |
| EP3228697A4 (en) | Highly efficient ethanol-fermentative bacteria | |
| EP3228698A4 (en) | Highly efficient ethanol-fermentative bacteria | |
| GB2571892B (en) | Incubator | |
| EP3228699A4 (en) | Highly efficient ethanol-fermentative bacteria | |
| EP3228696A4 (en) | Highly efficient ethanol-fermentative bacteria | |
| HK40000852A (zh) | 新细菌物种 | |
| GB2571506B (en) | Microorganism | |
| GB201711892D0 (en) | Improved culture methods | |
| GB201715203D0 (en) | Novel methods | |
| GB201715089D0 (en) | Novel methods | |
| GB201712386D0 (en) | Novel Methods | |
| GB201712596D0 (en) | Improved photobioreactor | |
| GB201605378D0 (en) | Modified microorganisms | |
| GB201605341D0 (en) | Modified microorganisms |